MIRABELLA MULLER: Open Payments
NPI 1497230320 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 40 payments from 14 companies in 2025. Trend: 2023 $1,562 · 2024 $1,659 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $222 |
| Incyte Corporation | 2 | $181 |
| GENZYME CORPORATION | 5 | $147 |
| ABBVIE INC. | 8 | $146 |
| Botanix SB Inc | 1 | $100 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $93 |
| UCB, Inc. | 4 | $89 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| PFIZER INC. | 3 | $60 |
| Janssen Biotech, Inc. | 2 | $45 |
Products named: OTEZLA, OPZELURA, DUPIXENT, SOFDRA, SKYRIZI, Bimzelx, COSENTYX, CIBINQO.
Industry payments across DC — which companies pay providers there.
